OptiNose, Inc.: Financial Report Reveals Stability
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
- Latest
- Trending
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Researchers at KIT's Institute for Advanced Membrane Technology (IAMT) have developed nanotubes with small pores that have a highly adsorbing ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.